Enviar artigo por via de e-mail Effect of Vascular Endothelial Growth Factor and Erythropoietin on Functional Activity of Fibroblasts and Multipotent Mesenchymal Stromal Cells
- Autores: Bondarenko N.1,2, Nikonorova Y.1, Surovtseva M.1, Lykov A.1,2, Poveshchenko O.1,2, Poveshchenko A.1,2, Pokushalov E.2, Romanov A.2, Konenkov V.1,2
-
Afiliações:
- Research Institute of Experimental and Clinical Lymphology, Siberian Division of the Russian Academy of Medical Sciences
- E. N. Meshalkin Novosibirsk Research Institute of Circulation Pathology, Ministry of Health of the Russian Federation
- Edição: Volume 160, Nº 4 (2016)
- Páginas: 498-501
- Seção: Experimental Biology
- URL: https://journals.rcsi.science/0007-4888/article/view/236755
- DOI: https://doi.org/10.1007/s10517-016-3206-8
- ID: 236755
Citar
Acesso aberto
Acesso está concedido
Somente assinantes
Resumo
The study examined the effect of VEGF and erythropoietin on proliferative and migratory activities of skin fibroblasts and multipotent mesenchymal stromal cells of human adipose tissue. VEGF stimulated proliferation and migration of fi broblasts, but produced no significant effect on functional activity of multipotent mesenchymal stem cells. Erythropoietin stimulated proliferation of both cell types, but did not affect their migration.
Sobre autores
N. Bondarenko
Research Institute of Experimental and Clinical Lymphology, Siberian Division of the Russian Academy of Medical Sciences; E. N. Meshalkin Novosibirsk Research Institute of Circulation Pathology, Ministry of Health of the Russian Federation
Autor responsável pela correspondência
Email: bond802888@yandex.ru
Rússia, Moscow; Novosibirsk
Yu. Nikonorova
Research Institute of Experimental and Clinical Lymphology, Siberian Division of the Russian Academy of Medical Sciences
Email: bond802888@yandex.ru
Rússia, Moscow
M. Surovtseva
Research Institute of Experimental and Clinical Lymphology, Siberian Division of the Russian Academy of Medical Sciences
Email: bond802888@yandex.ru
Rússia, Moscow
A. Lykov
Research Institute of Experimental and Clinical Lymphology, Siberian Division of the Russian Academy of Medical Sciences; E. N. Meshalkin Novosibirsk Research Institute of Circulation Pathology, Ministry of Health of the Russian Federation
Email: bond802888@yandex.ru
Rússia, Moscow; Novosibirsk
O. Poveshchenko
Research Institute of Experimental and Clinical Lymphology, Siberian Division of the Russian Academy of Medical Sciences; E. N. Meshalkin Novosibirsk Research Institute of Circulation Pathology, Ministry of Health of the Russian Federation
Email: bond802888@yandex.ru
Rússia, Moscow; Novosibirsk
A. Poveshchenko
Research Institute of Experimental and Clinical Lymphology, Siberian Division of the Russian Academy of Medical Sciences; E. N. Meshalkin Novosibirsk Research Institute of Circulation Pathology, Ministry of Health of the Russian Federation
Email: bond802888@yandex.ru
Rússia, Moscow; Novosibirsk
E. Pokushalov
E. N. Meshalkin Novosibirsk Research Institute of Circulation Pathology, Ministry of Health of the Russian Federation
Email: bond802888@yandex.ru
Rússia, Novosibirsk
A. Romanov
E. N. Meshalkin Novosibirsk Research Institute of Circulation Pathology, Ministry of Health of the Russian Federation
Email: bond802888@yandex.ru
Rússia, Novosibirsk
V. Konenkov
Research Institute of Experimental and Clinical Lymphology, Siberian Division of the Russian Academy of Medical Sciences; E. N. Meshalkin Novosibirsk Research Institute of Circulation Pathology, Ministry of Health of the Russian Federation
Email: bond802888@yandex.ru
Rússia, Moscow; Novosibirsk
